Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 307

The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.

The changing and dynamic epidemiology of meningococcal disease

Halperin, Scott A., Bettinger, Julie A., Greenwood, Brian, Harrison, Lee H., Jelfs, Jane, Ladhani, Shamez N., McIntyre, Peter, Ramsay, Mary E., Sáfadi, Marco A.P.·2012·Vaccine

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.vaccine.2011.12.032

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 65 references

Research works printed but not linked: 32

  1. el-Akkad, 1969, Epidemiology of cerebrospinal meningitis in Egypt during the last 50 years, J Egypt Public Health Assoc, 44, 260
  2. Nakhla, 2005, The changing epidemiology of meningococcal meningitis after introduction of bivalent A/C polysaccharide vaccine into school-based vaccination programs in Egypt, Vaccine, 23, 3288, 10.1016/j.vaccine.2005.01.084 · doi:10.1016/j.vaccine.2005.01.084
  3. Collard, 2010, Increase in Neisseria meningitidis serogroup W135, Niger, 2010 [letter], Emerg Infect Dis, 16, 1496, 10.3201/eid1609.100510 · doi:10.3201/eid1609.100510
  4. Mutonga, 2009, Epidemiology and risk factors for serogroup X meningococcal meningitis during an outbreak in western Kenya, 2005–2006, Am J Trop Med Hyg, 80, 619, 10.4269/ajtmh.2009.80.619 · doi:10.4269/ajtmh.2009.80.619
  5. WHO, 2006, Meningococcal disease, Uganda – update, Wkly Epidemiol Rec, 81, 62
  6. Sinclair, 2010, The epidemiology of meningocccal disease in India, Trop Med Int Health, 15, 1421, 10.1111/j.1365-3156.2010.02660.x · doi:10.1111/j.1365-3156.2010.02660.x
  7. Whittle, 1975, Group-C meningococcal meningitis in the northern savanna of Africa, Lancet, 1, 1377, 10.1016/S0140-6736(75)92281-3 · doi:10.1016/s0140-6736(75)92281-3
  8. Hu, 1991, Study on periodically prevalent feature for epidemic cerebrospinal meningitis in China, Chin J Epidemiol, 12, 136
  9. Hossain, 2009, Short report: increasing isolations of Neisseria meningitidis serogroup A from blood and cerebrospinal fluid in Dhaka, Bangladesh, 1999–2006, Am J Trop Med Hyg, 80, 615, 10.4269/ajtmh.2009.80.615 · doi:10.4269/ajtmh.2009.80.615
  10. Patel, 1926, Cerebrospinal fever in Bombay. A study of 170 consecutive cases during the years 1921–1924, Lancet, 11, 539, 10.1016/S0140-6736(01)27828-3 · doi:10.1016/s0140-6736(01)27828-3
  11. Australian Government Department of Health and Ageing, 2010, Communicable Diseases Surveillance: National Notifiable Diseases Surveillance System, Commun Dis Intell, 34, 214
  12. Patel, 1993, Epidemic meningococcal meningitis in central Australia, 1987–1991, Med J Aust, 158, 336, 10.5694/j.1326-5377.1993.tb121793.x · doi:10.5694/j.1326-5377.1993.tb121793.x
  13. Martin, 1998, New Zealand epidemic of meningococcal disease identified by a strain with phenotype B:4:P1.4, J Inf Dis, 177, 497, 10.1086/517385 · doi:10.1086/517385
  14. Ishola D, Borrow R, Findlow H, Trotter C, Ramsay M. P 068. Prevalence of serum bactericidal antibody to serogroup C Neisseria meningitidis in England, a decade after vaccine introduction (pages 174–5). The 11th European Meningococcal Group Meeting (EMGM) Congress 2011: Ljubljana, Slovenia, Abstract available at: <http://emgm.eu/meetings/emgm2011/abstracts.pdf> [accessed 04.10.11].
  15. Caugant DA, Løvoll Ø, Blystad H. P040. Meningococcal disease in Norway, 2009–2010: emergence of serogroup Y. EMGM (Pages 117–8). The 11th European Meningococcal Group Meeting (EMGM) Congress 2011: Ljubljana, Slovenia. Abstract available at: <http://emgm.eu/meetings/emgm2011/abstracts.pdf> [accessed 04.10.11].
  16. Vainio A, Toropainen M, Kuusi M, Virolaine A. P 037. Characteristics of invasive meningococcal serogroup Y isolates in Finland, 1995-2010 (Pages 111–2). The 11th European Meningococcal Group Meeting (EMGM) Congress 2011: Ljubljana, Slovenia. Abstract available at: <http://emgm.eu/meetings/emgm2011/abstracts.pdf> [accessed 04.11.11].
  17. Trotter C, Findlow H, Chadha H, Townsend K, Thompson D, Mabey L, et al. P 036. Seroprevalence of serum bactericidal antibodies against group W135 and Y meningococci in England in 2009 (pages 109–10). The 11th European Meningococcal Group Meeting (EMGM) Congress 2011: Ljubljana, Slovenia, Abstract available at: <http://emgm.eu/meetings/emgm2011/abstracts.pdf> [accessed 04.11.11]. · doi:10.1128/cvi.05515-11
  18. Advisory Committee on Immunization Practices (ACIP), 2011, Updated recommendations for use of meningococcal conjugate vaccines, 2010, MMWR Morb Mortal Wkly Rep, 60, 72
  19. Advisory Committee on Immunization Practices (ACIP), 2011, Licensure of a meningococcal conjugate vaccine for children aged 2 through 10 years and updated booster dose guidance for adolescents and other persons at increased risk for meningococcal disease, 2011, MMWR Morb Mortal Wkly Rep, 60, 1018
  20. Watkins, 2006, Enhanced surveillance of invasive meningococcal disease in Canada: 1 January, 2002, through 31 December, 2003, Can Commun Dis Rep, 32, 97
  21. Varughese, 1989, Meningococcal disease in Canada. Surveillance summary to 1987, Can Dis Wkly Rep, 15, 89
  22. National Advisory Committee on Immunization, 2009, Update on the invasive meningococcal disease and meningococcal vaccine conjugate recommendations. An Advisory Committee Statement (ACS), Can Commun Dis Rep, 36, 1
  23. Deeks, 1997, Surveillance of invasive meningococcal disease in Canada: 1995–1996, Can Commun Dis Rep, 23, 121
  24. 2009, Case definitions for communicable diseases under national surveillance, Can Commun Dis Rep, 35, 1
  25. Scheifele, 2009, IMPACT after 17 years: lessons learned about successful networking, Paediatr Child Health, 14, 33, 10.1093/pch/14.1.33 · doi:10.1093/pch/14.1.33
  26. Bettinger, 2010, The epidemiology of serogroup B meningococcal infections in Canada: IMPACT 2002–2009 [abstract], Can J Infect Dis Med Microbiol, 21, 179
  27. Law, 2006, Invasive meningococcal disease in Quebec, Canada, due to an emerging clone of ST-269 serogroup B meningococci with serotype antigen 17 and serosubtype antigen P1.19 (B:17:P1.19), J Clin Microbiol, 44, 2743, 10.1128/JCM.00601-06 · doi:10.1128/jcm.00601-06
  28. Tsang, 2002, Distribution of serogroups of Neisseria meningitidis and antigenic characterization of serogroup Y meningococci in Canada: January 1, 1999 to June 30, 2001, Can J Infect Dis, 13, 391, 10.1155/2002/891673 · doi:10.1155/2002/891673
  29. Tsang, 2007, Genetic and antigenic analysis of invasive serogroup Y Neisseria meningitidis isolates collected from 1999 to 2003 in Canada, J Clin Microbiol, 45, 1753, 10.1128/JCM.02134-06 · doi:10.1128/jcm.02134-06
  30. Lemos, 2006, Phenotypic characterization of Neisseria meningitidis strains isolated from invasive disease in Brazil from 1990 to 2001, J Med Microbiol, 55, 751, 10.1099/jmm.0.46451-0 · doi:10.1099/jmm.0.46451-0
  31. Pírez, 2004, Control de un brote epidémico de enfermedad meningocócica por N. meningitidis serogrupo B, Rev Med Uruguay, 20, 92
  32. Chacon-Cruz, 2011, Surveillance for invasive meningococcal disease in children, US-Mexico border, 2005–2008, Emerg Infect Dis, 17, 543, 10.3201/eid1703.101254 · doi:10.3201/eid1703.101254

Cited by

See all 307

Metadata

Authors
Halperin, S. A., Bettinger, J. A., Greenwood, B., Harrison, L. H., Jelfs, J., Ladhani, S. N., McIntyre, P., Ramsay, M. E., & Sáfadi, M. A. P.
Venue
Vaccine
Publisher
Elsevier BV
Published
2012-05
Volume
30
Pages
B26-B36
ISSN
0264-410X (ISSN-L)
OpenAlex
W2013735067
Cited by
307
References
65
FWCI
21.97
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The changing and dynamic epidemiology of meningococcal disease. https://app.cochat.ai/papers/10.1016/j.vaccine.2011.12.032
The paper
Halperin, S. A., Bettinger, J. A., Greenwood, B., Harrison, L. H., Jelfs, J., Ladhani, S. N., McIntyre, P., Ramsay, M. E., & Sáfadi, M. A. P. (2012). The changing and dynamic epidemiology of meningococcal disease. Vaccine. https://doi.org/10.1016/j.vaccine.2011.12.032

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.